Trending Now
Breaking news:
Business & Industry
Samsung Biologics to Buy US Drug Plant from GSK for $280M
On December 22, 2025, the news has been confirmed of Samsung Biologics to Buy US Drug Plant which is going to be its first US drug production facility from...
Popular:
Articles
Steps to Compliance: How Best to Prepare for...
Preparing for Russia’s regulation requirements might seem like a...
Articles
The Highest Safety for Highly Potent Pharmaceuticals
Biotechnologically manufactured drugs are one of the most important...
Articles
Articles
Who are the Top Vendors for Budget-Friendly Laboratory Supplies?
Whether professionals need a high-performance gas chromatography system or...
Articles
Future-proof vial filling – How flexibility Along the Line Defines Success
Vial fill-finish operations are changing faster than ever. New...
Articles
How Smart Digital Strategies are Leading...
The evolution of pharmaceutical manufacturing is driven largely by...
Articles
Rethinking Real-World Data Partnerships: How to...
Noah Nasser, CEO of datma
Most pharmaceutical companies have already...
Articles
Energy efficiency in pure steam generation:...
Pharmaceutical manufacturers face a twofold challenge. They not only...
Articles
Pharmacovigilance Systems Gaining Higher Ground with...
In a world that is marked by fast technological...
Articles
Overcoming The Pharmaceutical Supply Chain Disruptions
The pharmaceutical industry is undergoing a profound shift as...
Articles
Smart Sensors in Biomanufacturing Transform Fluid...
Smart Sensors & Monitoring in Fluid Systems in Biomanufacturing
Precision...
Interviews
Interviews
Improving Lab Efficiency Through Equipment Utilization
Q1: How can pharmaceutical laboratories quantify the financial impact...
Interviews
Trend Forecasting: Insights from Dr. Oliver...
Dr. Oliver Okle is a product and service manager...
Interviews
Jason Shuris of Indero on the...
Jason Shuris is the Chief Business Officer at Indero,...
Interviews
Executive Interview Series with datma CEO...
datma is a leading provider of federated Real-World Data...
Interviews
Ethical AI Investment: The Key to...
In this exclusive interview, World Pharma Today sits down...
White Papers
BioPharma
Press Releases
Press Releases
Syntegon Reports Strong Q3 2025 Growth and Margin Expansion
Syntegon Delivers Strong Growth and Margin Expansion in Q3 2025 with Accelerating Pharma Momentum and Profitability Gains Across All Segments
Q3 sales increased by 19% versus prior...
Press Releases
API China – The Pharmaceutical Ingredients Exhibition Concludes
API China, the first and longest-running pharmaceutical ingredients exhibition in China brought in over 30,000 visitors and around 1,200 exhibitors between 12 and 14 November 2025 at...
Press Releases
Almac announces multi-million-pound investment in Singapore
Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country.
The investment by Almac...
Press Releases
Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical...
Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase...
Press Releases
New data from Elsevier finds one in three corporate...
AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D
In its latest report, Researcher of the Future,...
Business & Industry
KLN Named Exclusive Distributor for Siemens Healthineers Point-of-Care Testing...
KLN Logistics Group Limited announced a strategic partnership between its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), and global medical technology leader Siemens Healthineers AG (Stock Code...
Business & Industry
API China Strengthens its Role as Asia’s Pharma Powerhouse
Heads to Chongqing for its 93rd edition
API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd edition at the Chongqing International Expo Center from 12–14 November...
Press Releases
swop 2025: Celebrating Ten Years of Industry Growth
Looking Ahead, Seizing New Opportunities — swop 2025 Marks Its 10th Anniversary in Shanghai
From November 25–27, 2025, the Shanghai World of Packaging (swop) will return to the...
Packaging & Labelling
swop 2025: A Decade of Global Packaging Innovation
A Decade of swop: Enabling Global Packaging Synergy via Integrated Industry Chain in 2025
As globalization advances and China steps up efforts to meet its “dual-carbon” goals (carbon...
Industry Reports
Business & Industry
Maximizing Portfolio Returns During Late-Stage Drug Development
Optimize late-stage pharmaceutical assets through strategic investment planning, risk management, and indication prioritization. Maximize R&D return on investment during the highest-stakes phase of drug development.
Industry Reports
India Outpaces Global Average With 2026 Medical Trend at 11.5 Percent: Aon Reports
Cardiovascular diseases, gastrointestinal conditions and cancer are top medical...
BioPharma
Biopharmaceutical CMO And CRO Market to Reach $60B by 2033
It should be highlighted that during the next ten...
Events
29th Edition Strategic Project & Portfolio Management for Pharma
Subscribe
- Gain full access to our premium content
- Never miss a story with active notifications
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Drug Devlopment
Redefining Success Metrics in Pharma Portfolio Management
Shift from traditional R&D metrics focused on milestone completion and budget adherence to outcome-based, value-focused metrics that measure strategic impact, learning velocity, and long-term portfolio…
Smarter Resource Planning for Complex Pharma Development Portfolios
Align limited resources with complex pharmaceutical portfolios through capacity forecasting, skills-based planning, and dynamic resource reallocation, improving execution outcomes without increasing costs or overburdening teams.
Packaging & Labelling
Bringing Seamlessness to the Pharmaceutical Supply Chain
It is well to be noted that freight audits, in addition to payment partnerships, go ahead and optimize the...
Manufacturing
More News
News
How High-Achievers Stay Future-Ready in Evolving Job Markets
Job markets today are transforming rapidly. In the past few years, we have experienced a paradigmatic shift in the way we work, with the creation of entirely...
Business & Industry
Proactive Risk Management as a Core Capability in Pharma...
Risk management in pharma is often treated as a reactive compliance box-ticking exercise. This article argues for reframing risk as a strategic competitive advantage. It…
Business & Industry
Rethinking Pipeline Value Beyond Peak Sales Forecasts
The traditional reliance on risk-adjusted Net Present Value (rNPV) and peak sales forecasts is failing to capture the true potential of modern pharmaceutical assets, particularly…
Business & Industry
Building Resilient Pharma Portfolios in an Era of Scientific...
Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This…
Clinical Trials
AI-Crafted Pill Succeeds Trials of Plaque Psoriasis Patients
Takeda Pharmaceutical from Japan said on December 17, 2025, that its experimental pill for a type of skin disease, which is developed using artificial intelligence, has succeeded...
BioPharma
Largest Vaccine Manufacturing Facility in Egypt Launched
Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the GENNVAX vaccine manufacturing...
Business & Industry
Sobi to Get Rights to Pozdeutinurad – Oral URAT1...
For a $950 million upfront, Sobi is all set to get rights to pozdeutinurad - oral URAT1 inhibitor that performed pretty well in the Phase II studies.
Sobi...
Technology
Business & Industry
Digital Platforms are Transforming how Pharma Portfolios are...
Integrated digital platforms enable real-time portfolio transparency, cross-functional coordination, and data-driven decision-making across global development teams, transforming portfolio management from spreadsheet-based processes into centralized intelligence…
Clinical Trials
Smarter Resource Planning for Complex Pharma Development Portfolios
Align limited resources with complex pharmaceutical portfolios through capacity forecasting, skills-based planning, and dynamic resource reallocation, improving execution outcomes without increasing costs or overburdening teams.
Business & Industry
Modernizing Governance Structures for Faster Portfolio Decisions
Accelerate pharmaceutical R&D decision-making by implementing modern governance frameworks that establish clear decision rights, defined escalation pathways and cross-functional ownership while maintaining strategic alignment and…
Videos
Loading playlist…